- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03152812
Functional Outcome of Free Muscle Flaps Versus Free Skin Flaps for Post-traumatic Foot Plantar Surface Reconstruction
May 20, 2017 updated by: alhussein Ahmed Mahmoud El-Dahshan
the investigators are trying to detect what is the best tissue constituent suitable for reconstruction of large post traumatic sof tissue defects of foot plantar surface
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Assiut
-
Assuit, Assiut, Egypt, 7771
- Assiut University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
any individual having post traumatic soft tissue defect of plantar surface requiring free flap reconstruction regardless to age
Description
Inclusion Criteria:
- Posttraumatic large soft tissue defects of plantar surface requiring free tissue transfer for coverage
- At any age
Exclusion Criteria:
1-defects that can be managed by local flaps 2-Non traumatic soft tissue defects
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
free skin flaps
|
use of free skin or free muscle flaps for reconstruction of plantar surface
|
|
free muscle flaps
|
use of free skin or free muscle flaps for reconstruction of plantar surface
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Time to mobilize
Time Frame: 2 years
|
2 years
|
|
Requirement of specialized Footwear
Time Frame: 2 years
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
flap ulceration
Time Frame: 2 years
|
2 years
|
|
Shear forces across the flap
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Amr El-Said Ali Ibrahim, MD, Assiut University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2017
Primary Completion (Anticipated)
March 1, 2019
Study Completion (Anticipated)
March 1, 2019
Study Registration Dates
First Submitted
May 12, 2017
First Submitted That Met QC Criteria
May 12, 2017
First Posted (Actual)
May 15, 2017
Study Record Updates
Last Update Posted (Actual)
May 23, 2017
Last Update Submitted That Met QC Criteria
May 20, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- salmaalhussein
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on plantar surface reconstruction by free flaps
-
Hospices Civils de LyonCompletedBone and Joint InfectionFrance
-
Indrayani Hospital and Cancer InstituteTata Capital Limited; Grant Medical Foundation Ruby hall ClinicCompletedSquamous Cell Carcinoma of Oral CavityIndia